Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Imports: Package Technology Unable To Guarantee Safety, GSK Says

Executive Summary

New drug packaging technologies will not be able to guarantee the safety of prescription drugs imported from Canada, GlaxoSmithKline and AstraZeneca told a House Government Reform/Wellness Subcommittee hearing June 12
Advertisement

Related Content

Manufacturers’ Anticounterfeiting Plans Sought In House Cmte. Investigation
FDA Counterfeiting Task Force To Look At Tighter Wholesaler Licensing
Reimportation Vote Planned In House; Advocates Say Must Be In Medicare
FDA Internet Pharmacy Concerns May Be Clearer If Medicare Rx Passes
FDA Internet Pharmacy Concerns May Be Clearer If Medicare Rx Passes
Closing The Books On Taxol: GAO Report Fuels Sen. Wyden’s Pricing Push
FDA Import Policy Discourages Promotion, Not Reimbursement – McClellan
Rx Imports: House Cmte. Tells FDA To Consider “Counterfeit-Proof” Packages
Rx Imports: House Cmte. Tells FDA To Consider “Counterfeit-Proof” Packages
GSK Selling Direct To Canadian Pharmacies, Auditing Orders To Curb Imports
Advertisement
UsernamePublicRestriction

Register

PS041979

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel